©The Author(s) 2025.
World J Hepatol. Oct 27, 2025; 17(10): 109583
Published online Oct 27, 2025. doi: 10.4254/wjh.v17.i10.109583
Published online Oct 27, 2025. doi: 10.4254/wjh.v17.i10.109583
Table 3 Treatment rates and disease-related variables before and after the educational video module, n (%)
| Treatment | Group | P value | |
| Pre-intervention (n = 43) | Post-intervention (n = 43) | ||
| Pharmacy treatment | 0.021 | ||
| No | 31 (72.1) | 22 (51.2) | |
| Yes | 12 (27.9) | 21 (48.8) | |
| Missing | 0 | 0 | |
| Acamprosate | 0.481 | ||
| No | 40 (93.0) | 38 (88.4) | |
| Yes | 3 (7.0) | 5 (11.6) | |
| Missing | 0 | 0 | |
| Disulfiram | |||
| No | 43 (100) | 43 (100) | - |
| Missing | 0 | 0 | - |
| Naltrexone | 0.201 | ||
| No | 34 (79.1) | 29 (67.4) | |
| Yes | 9 (20.9) | 14 (32.6) | |
| Missing | 0 | 0 | |
| Vivitrol | 0.171 | ||
| No | 34 (79.1) | 29 (67.4) | |
| Yes | 9 (20.9) | 14 (32.6) | |
| Missing | 0 | 0 | |
| Behavioral treatment | 0.0031 | ||
| No | 27 (62.8) | 12 (27.9) | |
| Yes | 16 (37.2) | 31 (72.1) | |
| Missing | 0 | 0 | |
| Inpatient treatment | 0.261 | ||
| No | 36 (83.7) | 39 (90.7) | |
| Yes | 7 (16.3) | 4 (9.3) | |
| Missing | 0 | 0 | |
| Outpatient treatment | 0.00021 | ||
| No | 39 (90.7) | 23 (53.5) | |
| Yes | 4 (9.3) | 20 (46.5) | |
| Missing | 0 | 0 | |
| Mutual aid | 0.101 | ||
| No | 28 (66.7) | 20 (47.6) | |
| Yes | 14 (33.3) | 22 (52.4) | |
| Missing | 1 | 1 | |
| Behavioral and pharmacologictreatment | 0.0071 | ||
| No | 37 (88.1) | 25 (59.5) | |
| Yes | 5 (11.9) | 17 (40.5) | |
| Missing | 1 | 1 | |
- Citation: Twohig P, Slocum ZP, Willet A, Schissel M, Balasanova AA, Scholten K, Warner J, Sempokuya T, Khoury N, Ashford A, Peeraphatdit TB. Novel educational video module about alcohol use disorder increases treatment rates and decreases return to alcohol use. World J Hepatol 2025; 17(10): 109583
- URL: https://www.wjgnet.com/1948-5182/full/v17/i10/109583.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i10.109583